Lifestyle factors and endothelial function

Nikolaos Papageorgiou1, Dimitris Tousoulis, Emmanuel Androulakis

  • 11st Cardiology Unit, Hippokration Hospital, Athens University Medical School, Athens, Greece. drnpapageorgiou@yahoo.com

Insights

Lifestyle changes can improve endothelial function, crucial for preventing atherosclerosis. However, genetic factors complicate understanding the full impact of these interventions on vascular health.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Preventive Medicine

Background:

  • Atherosclerotic disease is a global health burden.
  • Endothelial dysfunction and inflammation are central to atherosclerosis.
  • Endothelial dysfunction predicts ischemic events and adverse outcomes in acute coronary syndromes.

Purpose of the Study:

  • To explore the role of lifestyle modifications in improving endothelial function.
  • To investigate the complex interplay between genetics and environment in vascular health.

Main Methods:

  • Review of epidemiological research studies.
  • Analysis of clinical evidence on endothelial dysfunction and lifestyle.

Main Results:

  • Suboptimal lifestyle choices contribute to endothelial dysfunction and atherosclerosis.
  • Lifestyle modifications show promise for enhancing endothelial function.
  • The interaction between genetic background and environmental factors on vascular health remains unclear.

Conclusions:

  • Lifestyle interventions are important for managing endothelial dysfunction and atherosclerosis.
  • Further research is needed to elucidate the genetic-environmental interactions influencing vascular health and the efficacy of lifestyle interventions.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...